title: Evolution of the percutaneous penetration and distribution of uranyl nitrate as a function of skin-barrier integrity: an in vitro assessment.
abstract: As recommended by OECD Guidelines, percutaneous penetration studies consider intact skin, but rarely injured skin. Recent years have witnessed a growing concern for these two types of dermal exposure in the industry, particularly in the nuclear industry. The aim of this study was to show that a method based on an in vitro device can be used to realistically assess how skin-barrier alterations caused by occupational accidents can modify the percutaneous penetration and distribution of radionuclides, particularly uranium. Wounds encountered in the nuclear industry (i.e., nitric acid burns and abrasion) were simulated on hairless rat skin. Skin-barrier alterations were characterized by means of a histological study and by measuring transepidermal water loss (TEWL) and skin thickness. The percutaneous penetration of uranyl nitrate through intact or injured skin biopsies was then measured in vitro. The maximum uranium flux values obtained for intact skin, skin abrasion with stratum corneum removal, and skin exposed to 2 N HNO(3), 5 N HNO(3), and 14 N HNO(3) were, respectively, 0.6 +/- 0.02, 1.2 +/- 0.03, 1.2 +/- 0.04, 42.0 +/- 1.0, and 174.0 +/- 8.7 ng.cm(-2).h(-1). These results demonstrated that the percutaneous absorption of uranium increased with the increased impairment of the stratum corneum. TEWL, combined with maximum uranium flux values measured in vitro, yielded a good prediction of the percutaneous penetration of uranium through injured skin, previously observed in vivo. To conclude, this in vitro assay provides a conservative estimate of the percutaneous diffusion of uranium through intact or injured skin, making it a good alternative method for toxicological studies and risk assessments.
authors.affiliation: Institut de Radioprotection et de Sûreté Nucléaire, Laboratoire de Radiotoxicologie Expérimentale IRSN/DRPH/SRBE/LRTOX, Pierrelatte, France. fabrice.petitot@irsn.fr
authors.forename: Fabrice
authors.initials: F
authors.lastname: Petitot
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Moreels
authors.forename: François
authors.initials: F
authors.lastname: Paquet
mesh_terms: D000818:Animals; D006651:Histocytochemistry; D066298:In Vitro Techniques; D008297:Male; D051381:Rats; D054772:Rats, Hairless; D012867:Skin / Q000293:injuries* / Q000378:metabolism*; D012869:Skin Absorption; D014502:Uranyl Nitrate / Q000493:pharmacokinetics*; D014870:Water Loss, Insensible / Q000502:physiology
chemical_list: D014502:Uranyl Nitrate